Authors:
BROX AG
MANGEL J
HANLEY JA
STLOUIS G
MONGRAIN S
GAGNON RF
Citation: Ag. Brox et al., ERYTHROCYTOSIS AFTER RENAL-TRANSPLANTATION REPRESENTS AN ABNORMALITY OF INSULIN-LIKE GROWTH-FACTOR-I AND ITS BINDING-PROTEINS, Transplantation, 66(8), 1998, pp. 1053-1058
Citation: Rf. Gagnon et al., SURVEY OF THE MANAGEMENT OF ANEMIA IN END-STAGE RENAL-DISEASE (ESRD), Journal of the American Society of Nephrology, 8, 1997, pp. 328-328
Citation: Rf. Gagnon et al., METABOLIC-ACIDOSIS DURING URINARY RETENTION IN A PATIENT WITH A VESICOENTERIC FISTULA, Journal of the American Society of Nephrology, 8, 1997, pp. 489-489
Citation: Rf. Gagnon et al., RENAL OSTEODYSTROPHY IN MICE WITH CHRONIC-RENAL-FAILURE, Journal of the American Society of Nephrology, 8, 1997, pp. 2569-2569
Citation: Rf. Gagnon et al., ALTERED HEPATIC PRODUCTION OF INSULIN-LIKE GROWTH-FACTOR-I (IGF-1) AND ITS BINDING-PROTEINS (IGFBP) IN EXPERIMENTAL CHRONIC-RENAL-FAILURE (CRF), Journal of the American Society of Nephrology, 8, 1997, pp. 2869-2869
Citation: K. Yared et al., MECHANISM OF ACTION OF ANDROGEN TREATMENT ON THE ANEMIA OF EXPERIMENTAL CHRONIC-RENAL-FAILURE, Journal of the American Society of Nephrology, 8, 1997, pp. 2950-2950
Citation: A. Brox et al., THE PRODUCTION OF ERYTHROID COLONY-FORMING-UNITS IN THE BONE-MARROW AND SPLEEN OF NORMAL AND CHRONIC-RENAL-FAILURE C57BL 6 MICE/, Blood, 90(10), 1997, pp. 2732-2732
Citation: K. Yared et al., ANDROGENS INCREASE ERYTHROPOIETIN GENE-EXPRESSION IN THE MOUSE WITH CHRONIC-RENAL-FAILURE, Blood, 90(10), 1997, pp. 2777-2777
Authors:
GAGNON RF
LECLERC J
YARED K
LIBERMAN AS
KHURANA R
GUIMOND MC
VASILEVSKY M
Citation: Rf. Gagnon et al., SAFE AND EFFECTIVE ANTICOAGULATION WITH ENOXAPARIN DURING HEMODIALYSIS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 806-806
Citation: Rf. Gagnon et al., ABSENCE OF SIGNIFICANT ANEMIA IN 2 DIALYSIS PATIENTS WITHOUT ERYTHROPOIETIN TREATMENT AND BLOOD-TRANSFUSIONS - POSSIBLE ROLE OF INSULIN-LIKE GROWTH-FACTOR-I IN THE MAINTENANCE OF ERYTHROPOIESIS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1150-1150
Citation: A. Brox et al., ERYTHROPOIETIN TREATMENT OF THE ANEMIA OF MICE WITH CHRONIC-RENAL-FAILURE DOWN-REGULATES INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEIN-1, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1897-1897
Authors:
ZHANG F
LANEUVILLE P
GAGNON RF
MORIN B
BROX AG
Citation: F. Zhang et al., EFFECT OF CHRONIC-RENAL-FAILURE ON THE EXPRESSION OF ERYTHROPOIETIN MESSAGE IN A MURINE MODEL, Experimental hematology, 24(13), 1996, pp. 1469-1474
Citation: Ag. Brox et al., SUBTHERAPEUTIC ERYTHROPOIETIN AND INSULIN-LIKE GROWTH-FACTOR-I CORRECT THE ANEMIA OF CHRONIC-RENAL-FAILURE IN THE MOUSE, Kidney international, 50(3), 1996, pp. 937-943
Citation: F. Zhang et al., ANEMIA OF CHRONIC-RENAL-FAILURE - CHARACTERIZATION IN THE MOUSE AND CORRECTION WITH HUMAN RECOMBINANT ERYTHROPOIETIN, Nephron, 72(4), 1996, pp. 654-661
Authors:
KHURANA R
GAGNON RF
CIANFLONE K
LECLERC J
VASILEVSKY M
Citation: R. Khurana et al., INTRADIALYTIC CHANGES IN CIRCULATING LIPIDS WITH ANTICOAGULATION BY THE LOW-MOLECULAR-WEIGHT HEPARIN ENOXAPARIN, Journal of the American Society of Nephrology, 6(3), 1995, pp. 494-494
Citation: Rf. Gagnon et al., UROKINASE ENHANCEMENT OF RIFAMPIN ACTIVITY AGAINST EXPERIMENTAL STAPHYLOCOCCUS-EPIDERMIDIS BIOFILMS IN SPENT PD FLUID, Journal of the American Society of Nephrology, 6(3), 1995, pp. 530-530
Citation: E. Jonasch et al., INSULIN-LIKE GROWTH-FACTOR-I (IGF-1), IGF1 BINDING-PROTEINS (BP1, BP3) AND ERYTHROPOIETIN (EPO) SERUM LEVELS IN HEMODIALYSIS-PATIENTS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 579-579
Citation: Ag. Brox et Rf. Gagnon, TREATMENT OF MICE WITH INSULIN-LIKE GROWTH-FACTOR-I (IGF-1) COMBINED TO SUBTHERAPEUTIC ERYTHROPOIETIN (EPO) CORRECTS THE ANEMIA OF CHRONIC-RENAL-FAILURE (CRF), Journal of the American Society of Nephrology, 6(3), 1995, pp. 733-733
Authors:
SUBANG MC
STEWARTPHILLIPS JL
PAPPU AS
SUBANG R
GAGNON RF
Citation: Mc. Subang et al., POSSIBLE ROLE OF MEVALONATE IN THE HYPERCHOLESTEROLEMIA SEEN IN EXPERIMENTAL CHRONIC-RENAL-FAILURE, Nephron, 69(2), 1995, pp. 151-154
Citation: Rf. Gagnon et al., THE DIFFERENTIAL EFFECT OF PERITONEAL-DIALYSIS SOLUTIONS ON ANTIBIOTIC-ACTIVITY AGAINST RIFAMPIN-RESISTANT AND RIFAMPIN-SENSITIVE STAPHYLOCOCCUS-EPIDERMIDIS BIOFILMS, Journal of the American Society of Nephrology, 5(3), 1994, pp. 414-414
Citation: Rj. Morcos et al., COMPARATIVE ANTIBIOTIC-ACTIVITY AGAINST BIOFILMS OF STAPHYLOCOCCUS-EPIDERMIDIS STRAINS SENSITIVE AND RESISTANT TO RIFAMPIN, Journal of the American Society of Nephrology, 5(3), 1994, pp. 422-422
Citation: Gk. Richards et al., THE DIVERGENT ACTIVITY OF AMINOGLYCOSIDE ANTIBIOTICS IN COMBINATION WITH RIFAMPIN AGAINST STAPHYLOCOCCUS-EPIDERMIDIS BIOFILMS, Journal of the American Society of Nephrology, 5(3), 1994, pp. 425-425
Citation: Gk. Richards et Rf. Gagnon, THE CONTINUING ENIGMA OF IMPLANT-ASSOCIATED INFECTIONS, International journal of artificial organs, 16(11), 1993, pp. 747-748